First year results are in - all 32 participants in the Pioneer Accountable Care Organization (ACO) initiative showed success in improving quality. However, not as much success was made in cost savings.
The participants in the Obama administration's most aggressive experiment with accountable care had better success improving quality than lowering costs, according to first-year results revealed in a published report.
All 32 of the accountable care organizations in the program improved patient care and patient satisfaction against benchmarks, according to results shared with the Wall Street Journal in advance of their public release. Only 13 achieved enough savings that they qualified to share some of that money. Two ended up spending more on the assigned beneficiaries than traditional Medicare fee-for-service and will owe the government $4 million.
The challenge of assuming financial risk for achieving the targets has prompted several of the participants to consider leaving the program and potentially entering more flexible ACO contracts in the Medicare Shared Savings Program.
Read the full story here: http://bit.ly/18lgBFv
First year results are in - all 32 participants in the Pioneer Accountable Care Organization (ACO) initiative showed success in improving quality. However, not as much success was made in cost savings. Modern Healthcare reports:
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen